Yuto Yamada Selected Research

Yuto Yamada Research Topics

Disease

15	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 05/2020
9	Neoplasms (Cancer) 07/2023 - 08/2016
3	Pathologic Constriction (Stenosis) 01/2024 - 12/2020
3	Shock 07/2023 - 09/2018
2	Chronic Pancreatitis 10/2023 - 01/2023
2	Hemorrhage 04/2023 - 12/2020
2	Infections 01/2023 - 07/2022
2	Neutropenia 01/2023 - 07/2021
2	Duodenal Obstruction 01/2023 - 01/2023
2	Cholangitis 01/2023 - 07/2021
2	Neoplasm Metastasis (Metastasis) 09/2022 - 08/2021
2	Sarcopenia 07/2021 - 04/2021
2	Anorexia 04/2021 - 01/2021
1	Hypertriglyceridemia 05/2023
1	Chronic Renal Insufficiency 05/2023
1	Ureteral Obstruction 05/2023
1	Fibrosis (Cirrhosis) 05/2023
1	Stroke (Strokes) 04/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023
1	Body Weight (Weight, Body) 02/2023
1	Fever (Fevers) 01/2023
1	Hyperplasia 01/2023
1	Hyperthyroidism 01/2023
1	COVID-19 12/2022
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2022
1	Pancreatitis 04/2022
1	Schizophrenia (Dementia Praecox) 03/2022
1	Turcot syndrome 01/2022
1	Carcinogenesis 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021
1	Enteritis 10/2021
1	Adenocarcinoma 10/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 10/2021
1	Cachexia 07/2021
1	Hemobilia 07/2021
1	Disease Progression 07/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Diverticulitis 01/2021
1	Diarrhea 01/2021
1	Rupture 12/2020
1	Klatskin Tumor 12/2020

Drug/Important Bio-Agent (IBA)

9	Gemcitabine FDA Link 10/2021 - 05/2020
7	130-nm albumin-bound paclitaxelIBA 08/2021 - 05/2020
6	folfirinoxIBA 08/2021 - 05/2020
3	MetalsIBA 04/2023 - 01/2023
2	PlasticsIBA 01/2024 - 01/2023
2	Lithium Carbonate (Eskalith)FDA LinkGeneric 01/2023 - 03/2022
1	Fibric Acids (Fibrates)IBA 05/2023
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 05/2023
1	PPAR alphaIBA 05/2023
1	Adenine FDA LinkGeneric 05/2023
1	Urea (Carbamide)FDA LinkGeneric 05/2023
1	CreatinineIBA 05/2023
1	NitrogenIBA 05/2023
1	Hemoglobins (Hemoglobin)IBA 05/2023
1	Saline SolutionIBA 04/2023
1	osimertinibIBA 02/2023
1	ErbB Receptors (EGF Receptor)IBA 02/2023
1	C-Reactive ProteinIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Clozapine (Clozaril)FDA LinkGeneric 01/2023
1	AntigensIBA 11/2022
1	CarbohydratesIBA 11/2022
1	Vancomycin FDA LinkGeneric 07/2022
1	Antidepressive Agents (Antidepressants)IBA 03/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	dimemorfan (AT 17)IBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	Bendamustine Hydrochloride FDA Link 12/2021
1	obinutuzumabIBA 12/2021
1	dihydrouracilIBA 10/2021
1	UracilIBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Trans Fatty AcidsIBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021

Therapy/Procedure

10	Stents 10/2023 - 12/2020
10	Drug Therapy (Chemotherapy) 11/2022 - 08/2016
5	Therapeutics 04/2022 - 05/2020
3	Self Expandable Metallic Stents 04/2023 - 01/2023
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 07/2023 - 04/2023
2	Neoadjuvant Therapy 10/2021 - 04/2021
1	Palliative Care (Palliative Therapy) 07/2023
1	Surgical Instruments (Clip) 04/2023
1	Injections 01/2023
1	Terminal Care (Care, Terminal) 12/2022
1	Pancreatectomy 09/2022
1	Adjuvant Chemotherapy 05/2022
1	Sphincterotomy 04/2022
1	Catheters 06/2021
1	Treatment Delay 04/2021